INNOVUS PHARMACEUTICALS INC (OTCMKTS:INNV) Sellers Declined Their Shorts By 73.33%

It was showed a decrease on INNOVUS PHARMACEUTICALS INC (OTCMKTS:INNV)’s shares shorted with 73.33%. FINRA announced shares shorted of INNV’s total 1,200 shares. The 4,500 previous shares are down with 73.33%.

The stock decreased 4.84% or $0.003 during the last trading session, touching $0.059.Currently Innovus Pharmaceuticals, Inc. is after 0.00% change in last January 16, 2018. INNV has also shares volume. The stock the S&P500 by 0.00%.

Innovus Pharmaceuticals, Inc., a pharmaceutical company, engages in the commercialization, licensing, and development of non-prescription medicine and consumer care products in the United States.The firm is valued at $14.45 million. The Company’s products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph-compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream that enhances penile sensitivity; Zestra Glide, a water longer lasting lubricant; Vesele, a proprietary oral supplement of Arginine sexual and cognitive functions; and Androferti, a natural supplement to support overall male reproductive health and sperm quality.Last it reported negative earnings. The firm also offers Beyond Human testosterone booster, Ketones, krill oil, Omega 3 fish oil, Vision Formula, blood sugar, colon cleanse, green coffee extract, and growth agent; RecalMax for brain health; and UriVarx, a proprietary supplement for overactive bladder and urinary incontinence.

For more Innovus Pharmaceuticals, Inc. (OTCMKTS:INNV) news released briefly go to: Seekingalpha.com, Seekingalpha.com, Seekingalpha.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “Medicare reimbursement set for Innovus Pharma’s GlucoGorx; shares up 5% – Seeking Alpha” released on October 23, 2018, “Innovus Pharma expands into CBD oil-based products market – Seeking Alpha” on October 18, 2018, “Innovus Pharma’s UriVarx shows positive effect in overactive bladder study – Seeking Alpha” with a publish date: February 07, 2018, “Innovus Pharma merges with Novalere FP, nabs rights to steroid nasal spray – Seeking Alpha” and the last “Innovus Pharmaceuticals announces $3.17M private placement – Seeking Alpha” with publication date: December 31, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.